HeartCheck app for long-term follow-up of coronary artery disease
Tests the HeartCheck app for long-term follow-up in people after a heart attack.
Plain-language title generated from the registry record
Registry title: Digital Long-term Follow-up of Patients With Coronary Artery Disease
Key facts
- Where
- Arendal and Oslo, NorwaySee the 2 sites
Where in Norway
- Sørlandet hospital ArendalArendal, NorwayTaking people
- Oslo University Hospital UllevålOslo, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oslo University Hospital
- Trial code
- NCT07720349
- Record updated
- 31 July 2026
- Original description
The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.Read full original descriptionShow less
Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial
The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.
Inclusion: >18 years of age; survived a recent (<30 days) AMI and/or PCI; access to a smartphone or tablet; signed written informed consent.
Exclusion: patient is unable to comply with the study procedures due to severe comorbidities or high age; patient does not understand Norwegian.